PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p-Reference-Cited by-同舟云学术

PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p

Published:2017-02-09 Issue:9 Volume:8 Page:15894-15911
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Audrito Valentina¹²,Serra Sara¹²,Stingi Aureliano¹²,Orso Francesca³,Gaudino Federica¹²,Bologna Cinzia¹²,Neri Francesco¹,Garaffo Giulia³,Nassini Romina⁴,Baroni Gianna⁵,Rulli Eliana⁶,Massi Daniela⁵,Oliviero Salvatore¹⁷,Piva Roberto³,Taverna Daniela³,Mandalà Mario⁸,Deaglio Silvia¹²

Affiliation:

1. Human Genetics Foundation (HuGeF), Turin, Italy

2. Department of Medical Sciences, University of Turin, Turin, Italy

3. Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy

4. Department of Health Sciences, University of Florence, Italy

5. Department of Surgery and Translational Medicine, University of Florence, Italy

6. Methodology for Clinical Research Laboratory, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy

7. Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy

8. Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-21

2. Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy;Journal for ImmunoTherapy of Cancer;2024-08

3. Integrative analysis of genomic and epigenomic regulation reveals miRNA mediated tumor heterogeneity and immune evasion in lower grade glioma;Communications Biology;2024-07-06

4. Integrative analysis of genomic and epigenomic regulation reveals microRNA regulatory network mediated tumor heterogeneity and immune evasion in lower grade glioma;2024-02-09

5. PD-L1 Expression in Pituitary Neuroendocrine Tumors/Pituitary Adenomas;Cancers;2023-09-08